PROM1 and glioblastoma: CD133 is a classical marker of CSC, which is highly expressed in many solid tumors such as glioblastoma, hepatocellular carcinoma, and pancreatic cancer, but lowly expressed in normal tissues (e.g., hematopoietic stem cells, endothelial progenitor cells).